These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 28049687)

  • 1. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene editing in human development: ethical concerns and practical applications.
    Rossant J
    Development; 2018 Jul; 145(16):. PubMed ID: 30045910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CRISPR-Cas9, germinal cells and human embryo].
    Jouannet P
    Biol Aujourdhui; 2017; 211(3):207-213. PubMed ID: 29412130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genome editing in human embryos: ethical concerns and practical applications].
    Akutsu H
    Rinsho Ketsueki; 2019; 60(9):1033-1045. PubMed ID: 31597825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new milestone in human embryo editing].
    Jordan B
    Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
    Gumer JM
    New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethics of creating genetically modified children using genome editing.
    Ishii T
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 technology: applications in oocytes and early embryos.
    Zhang YR; Yin TL; Zhou LQ
    J Transl Med; 2023 Oct; 21(1):746. PubMed ID: 37875936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
    Musunuru K
    JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legality of Embryonic Gene Editing in Australia.
    Taylor-Sands M; Gyngell C
    J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing the human genome: where ART and science intersect.
    Hershlag A; Bristow SL
    J Assist Reprod Genet; 2018 Aug; 35(8):1367-1370. PubMed ID: 29882090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
    Memi F; Ntokou A; Papangeli I
    Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
    Tomlinson T
    Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carry on editing.
    Greenfield A
    Br Med Bull; 2018 Sep; 127(1):23-31. PubMed ID: 30202929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision editing in the human embryo.
    Aschheim K
    Nat Biotechnol; 2017 Sep; 35(9):832. PubMed ID: 28898212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Back from Hong Kong or ethics at the time of a genetic increase of the human person].
    Chneiweiss H
    Med Sci (Paris); 2019 Mar; 35(3):263-265. PubMed ID: 30931912
    [No Abstract]   [Full Text] [Related]  

  • 18. Embryo editing takes another step to clinic.
    Servick K
    Science; 2017 Aug; 357(6350):436-437. PubMed ID: 28774906
    [No Abstract]   [Full Text] [Related]  

  • 19. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
    Kang X; He W; Huang Y; Yu Q; Chen Y; Gao X; Sun X; Fan Y
    J Assist Reprod Genet; 2016 May; 33(5):581-588. PubMed ID: 27052831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Transgenic Core Facility's Experience in Genome Editing Revolution.
    Yuan CL; Hu YC
    Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.